Physicochemical Properties
| Molecular Formula | C18H36O | 
| Molecular Weight | 268.48 | 
| Exact Mass | 268.276 | 
| CAS # | 502-69-2 | 
| PubChem CID | 10408 | 
| Appearance | Colorless to light yellow liquid | 
| Density | 0.8±0.1 g/cm3 | 
| Boiling Point | 316.8±10.0 °C at 760 mmHg | 
| Flash Point | 95.1±12.6 °C | 
| Vapour Pressure | 0.0±0.7 mmHg at 25°C | 
| Index of Refraction | 1.440 | 
| LogP | 7.26 | 
| Hydrogen Bond Donor Count | 0 | 
| Hydrogen Bond Acceptor Count | 1 | 
| Rotatable Bond Count | 12 | 
| Heavy Atom Count | 19 | 
| Complexity | 220 | 
| Defined Atom Stereocenter Count | 0 | 
| SMILES | CC(C)CCCC(C)CCCC(C)CCCC(=O)C  | 
                            
| InChi Key | WHWDWIHXSPCOKZ-UHFFFAOYSA-N | 
| InChi Code | InChI=1S/C18H36O/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19/h15-17H,6-14H2,1-5H3 | 
| Chemical Name | 6,10,14-trimethylpentadecan-2-one | 
| HS Tariff Code | 2934.99.9001 | 
| Storage | 
                                     Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month  | 
                            
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) | 
Biological Activity
| References | 
                                    
                                         [1]. Albizia lebbeck and Albizia zygia volatile oils exhibit anti-nociceptive and anti-inflammatory properties in pain models.J Ethnopharmacol. 2021 Mar 25;268:113676. [2]. Essential oil composition and antibacterial activity of Lindera nacusua (D. Don) Merr. Nat Prod Res. 2016 Dec;30(23):2704-2706.  | 
                            
| Additional Infomation | 
                                    
                                        Hexahydrofarnesyl acetone is a ketone. 6,10,14-Trimethylpentadecan-2-one has been reported in Leea guineensis, Pinellia ternata, and other organisms with data available.  | 
                            
Solubility Data
| Solubility (In Vitro) | DMSO : 33.33 mg/mL (124.14 mM) | 
| Solubility (In Vivo) | 
                                    Solubility in Formulation 1:  ≥ 2.5 mg/mL (9.31 mM) (saturation unknown)  in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.31 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (9.31 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.)  | 
                            
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7247 mL | 18.6234 mL | 37.2467 mL | |
| 5 mM | 0.7449 mL | 3.7247 mL | 7.4493 mL | |
| 10 mM | 0.3725 mL | 1.8623 mL | 3.7247 mL |